As mental health treatment evolves, MindMed’s advancing psychedelic pipeline and strong 2025 rally have Jones Trading penciling in gains that could more than quadruple the stock from here.
Wall Street Thinks This 1 Psychedelic Stock Can Gain 335% in 2026
